S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61

PreveCeutical Medical Stock Forecast, Price & News

0.00 (0.00%)
(As of 12/8/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
140,083 shs
Average Volume
238,035 shs
Market Capitalization
$10.03 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive PRVCF News and Ratings via Email

Sign-up to receive the latest news and ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter.

PreveCeutical Medical logo

About PreveCeutical Medical

PreveCeutical Medical, Inc. engages in licensing, branding, and marketing of nutraceutical and wellness products. The company was founded by Stephen Van Deventer, Kimberly Van Deventer, Greg Reid, Shabira Rajan, Mak Jawadekar, Harry Parekh, Nicole Goncalves-Krysinski, Lish Rebman, and Sydney Cole on December 15, 2014 and is headquartered in Vancouver, Canada.


March 17, 2021 |  ca.finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Private households
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
Book Value
($0.01) per share


Net Income
$-2.84 million
Pretax Margin




Free Float
Market Cap
$10.03 million
Not Optionable

Company Calendar

Fiscal Year End


Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

PreveCeutical Medical (OTCMKTS:PRVCF) Frequently Asked Questions

How has PreveCeutical Medical's stock price been impacted by COVID-19 (Coronavirus)?

PreveCeutical Medical's stock was trading at $0.0149 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PRVCF shares have increased by 31.5% and is now trading at $0.0196.
View which stocks have been most impacted by COVID-19

Are investors shorting PreveCeutical Medical?

PreveCeutical Medical saw a decrease in short interest during the month of October. As of October 29th, there was short interest totaling 1,600 shares, a decrease of 46.7% from the October 14th total of 3,000 shares. Based on an average trading volume of 66,300 shares, the short-interest ratio is presently 0.0 days.
View PreveCeutical Medical's Short Interest

Who are PreveCeutical Medical's key executives?

PreveCeutical Medical's management team includes the following people:
  • Stephen van Deventer, Chairman & Chief Executive Officer
  • Makarand Jawadekar, President, Director & Chief Science Officer
  • Shabira Rajan, Chief Financial Officer & Controller
  • Harry Parekh, Chief Research Officer
  • Alicia Rebman, Marketing Director

What is PreveCeutical Medical's stock symbol?

PreveCeutical Medical trades on the OTCMKTS under the ticker symbol "PRVCF."

How do I buy shares of PreveCeutical Medical?

Shares of PRVCF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PreveCeutical Medical's stock price today?

One share of PRVCF stock can currently be purchased for approximately $0.02.

How much money does PreveCeutical Medical make?

PreveCeutical Medical has a market capitalization of $10.03 million.

What is PreveCeutical Medical's official website?

The official website for PreveCeutical Medical is www.preveceutical.com.

Where are PreveCeutical Medical's headquarters?

PreveCeutical Medical is headquartered at 1177 West Hastings Street Suite 2200, Vancouver A1, V6E2K3.

How can I contact PreveCeutical Medical?

PreveCeutical Medical's mailing address is 1177 West Hastings Street Suite 2200, Vancouver A1, V6E2K3. The company can be reached via phone at (604) 416-7777, via email at [email protected], or via fax at 778-945-6290.

This page was last updated on 12/9/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.